Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1678546
PUBLISHER: Grand View Research | PRODUCT CODE: 1678546
Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Market Size & Trends:
The global contraceptive drugs and devices market size was estimated at USD 31.18 billion in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. Several factors are contributing to the growth of the contraceptive market. Increasing awareness and education about reproductive health, a rising demand for family planning methods, improved healthcare infrastructure and access, and a shift in consumer preferences toward more effective and convenient contraceptive options are all key drivers. These factors have led to a global demand for a wide range of contraceptive choices, including oral contraceptives and long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants.
Furthermore, health concerns related to teenage pregnancies, increased awareness of modern contraception methods, and a growing preference for oral contraceptives as the primary means of preventing unplanned pregnancies are anticipated to drive market growth during the forecast period. In addition, advancements in product innovation, government initiatives, and a focus on women's empowerment and rights have contributed to this market growth. For instance, in July 2023, Opill, a progestin-only oral contraceptive pill, got approval by the FDA for nonprescription use.
Implementing programs aimed at reducing unwanted pregnancies and related healthcare costs, along with increasing awareness among users, is expected to drive growth in the industry during the forecast period. According to the 2022 State of World Population Report by the United Nations Population Fund (UNFPA), approximately 121 million pregnancies occur worldwide each year, with nearly half of them being unintended.
Moreover, governments in developing countries are undertaking steps to increase awareness and access to contraceptives. For instance, in October 2023, the Karnataka Health Department in India launched two new contraceptive methods for women under the National Family Planning Programme. The sub-dermal implant and subcutaneous injection were made available at government-run health centers to promote reproductive and sexual health by extending the interval between two births. Such methods are expected to promote the use of contraception in developing countries and contribute to the market's growth.
Global Contraceptive Drugs And Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product, and region.
- Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Contraceptive Drugs
- Contraceptive Pills
- Patch
- Injectable
- Contraceptive Devices
- Condoms
- Male Condoms
- Female Condoms
- Subdermal Implants
- Intrauterine Devices (IUDs)
- Copper IUDs
- Hormonal IUDs
- Vaginal Ring
- Diaphragm
- Regional Outlook (Revenue, USD Billion, 2018-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: 978-1-68038-032-3
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Secondary Sources
- 1.4.2. List of Primary Sources
- 1.4.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Outlook
- 2.2.2. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamic
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Increasing awareness and education on reproductive health
- 3.2.1.2. Rising demand for family planning methods
- 3.2.1.3. Growing healthcare infrastructure and access
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Side effects and health concerns
- 3.2.3. Industry Challenges
- 3.2.4. Market Opportunity Analysis
- 3.2.1. Market Drivers Analysis
- 3.3. Contraceptive Drugs and Devices Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Analysis
Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis
- 4.1. Definition and Scope
- 4.2. Product Market Share Analysis, 2024 & 2030
- 4.3. Segment Dashboard
- 4.4. Contraceptive Drugs and Devices Market: By Product, 2018 to 2030
- 4.4.1. Contraceptive Drugs
- 4.4.1.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.1.2. Contraceptive Pills
- 4.4.1.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.1.3. Patch
- 4.4.1.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.1.4. Injectable
- 4.4.1.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2. Contraceptive Devices
- 4.4.2.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.2. Condoms
- 4.4.2.2.1. Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.2.2. Male Condoms
- 4.4.2.2.2.1. Male Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.2.3. Female Condoms
- 4.4.2.2.3.1. Female Condoms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.3. Subdermal Implants
- 4.4.2.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.4. Intrauterine Devices (IUDs)
- 4.4.2.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.4.2. Copper IUDs
- 4.4.2.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.4.3. Hormonal IUDs
- 4.4.2.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.5. Vaginal Ring
- 4.4.2.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.2.6. Diaphragm
- 4.4.2.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 4.4.1. Contraceptive Drugs
Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis by Region, Product
- 5.1. Definition and Scope
- 5.2. Regional Market Share Analysis, 2024 & 2030
- 5.3. Regional Market Dashboard
- 5.4. Contraceptive Drugs and Devices Market Share, By Region, 2024 & 2030, (USD Billion)
- 5.5. North America
- 5.5.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.5.2. U.S.
- 5.5.2.1. U.S. Key Country Dynamics
- 5.5.2.2. Regulatory Landscape and Reimbursement Scenario
- 5.5.2.3. Competitive Insights
- 5.5.2.4. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.5.3. Canada
- 5.5.3.1. Canada Key Country Dynamics
- 5.5.3.2. Regulatory Landscape and Reimbursement Scenario
- 5.5.3.3. Competitive Insights
- 5.5.3.4. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.5.4. Mexico
- 5.5.4.1. Mexico Key Country Dynamics
- 5.5.4.2. Regulatory Landscape and Reimbursement Scenario
- 5.5.4.3. Competitive Insights
- 5.5.4.4. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6. Europe
- 5.6.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.2. UK
- 5.6.2.1. UK Key Country Dynamics
- 5.6.2.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.2.3. Competitive Insights
- 5.6.2.4. U.K. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.3. Germany
- 5.6.3.1. Germany Key Country Dynamics
- 5.6.3.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.3.3. Competitive Insights
- 5.6.3.4. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.4. France
- 5.6.4.1. France Key Country Dynamics
- 5.6.4.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.4.3. Competitive Insights
- 5.6.4.4. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.5. Italy
- 5.6.5.1. Italy Key Country Dynamics
- 5.6.5.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.5.3. Competitive Insights
- 5.6.5.4. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.6. Spain
- 5.6.6.1. Spain Key Country Dynamics
- 5.6.6.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.6.3. Competitive Insights
- 5.6.6.4. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.7. Denmark
- 5.6.7.1. Denmark Spain Key Country Dynamics
- 5.6.7.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.7.3. Competitive Insights
- 5.6.7.4. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.8. Sweden
- 5.6.8.1. Sweden Key Country Dynamics
- 5.6.8.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.8.3. Competitive Insights
- 5.6.8.4. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6.9. Norway
- 5.6.9.1. Norway Key Country Dynamics
- 5.6.9.2. Regulatory Landscape and Reimbursement Scenario
- 5.6.9.3. Competitive Insights
- 5.6.9.4. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7. Asia Pacific
- 5.7.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7.2. China
- 5.7.2.1. China Key Country Dynamics
- 5.7.2.2. Regulatory Landscape and Reimbursement Scenario
- 5.7.2.3. Competitive Insights
- 5.7.2.4. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7.3. Japan
- 5.7.3.1. Japan Key Country Dynamics
- 5.7.3.2. Regulatory Landscape and Reimbursement Scenario
- 5.7.3.3. Competitive Insights
- 5.7.3.4. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7.4. India
- 5.7.4.1. India Key Country Dynamics
- 5.7.4.2. Regulatory Landscape and Reimbursement Scenario
- 5.7.4.3. Competitive Insights
- 5.7.4.4. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7.5. South Korea
- 5.7.5.1. South Korea Key Country Dynamics
- 5.7.5.2. Regulatory Landscape and Reimbursement Scenario
- 5.7.5.3. Competitive Insights
- 5.7.5.4. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7.6. Australia
- 5.7.6.1. Australia Key Country Dynamics
- 5.7.6.2. Regulatory Landscape and Reimbursement Scenario
- 5.7.6.3. Competitive Insights
- 5.7.6.4. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7.7. Thailand
- 5.7.7.1. Thailand Key Country Dynamics
- 5.7.7.2. Regulatory Landscape and Reimbursement Scenario
- 5.7.7.3. Competitive Insights
- 5.7.7.4. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.8. Latin America
- 5.8.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.8.2. Brazil
- 5.8.2.1. Brazil Key Country Dynamics
- 5.8.2.2. Regulatory Landscape and Reimbursement Scenario
- 5.8.2.3. Competitive Insights
- 5.8.2.4. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.8.3. Argentina
- 5.8.3.1. Argentina Key Country Dynamics
- 5.8.3.2. Regulatory Landscape and Reimbursement Scenario
- 5.8.3.3. Competitive Insights
- 5.8.3.4. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.9. Middle East and Africa (MEA)
- 5.9.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.9.2. South Africa
- 5.9.2.1. South Africa Key Country Dynamics
- 5.9.2.2. Regulatory Landscape and Reimbursement Scenario
- 5.9.2.3. Competitive Insights
- 5.9.2.4. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.9.3. Saudi Arabia
- 5.9.3.1. Saudi Arabia Key Country Dynamics
- 5.9.3.2. Regulatory Landscape and Reimbursement Scenario
- 5.9.3.3. Competitive Insights
- 5.9.3.4. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.9.4. UAE
- 5.9.4.1. UAE Key Country Dynamics
- 5.9.4.2. Regulatory Landscape and Reimbursement Scenario
- 5.9.4.3. Competitive Insights
- 5.9.4.4. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.9.5. Kuwait
- 5.9.5.1. Kuwait Key Country Dynamics
- 5.9.5.2. Regulatory Landscape and Reimbursement Scenario
- 5.9.5.3. Competitive Insights
- 5.9.5.4. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments/ Strategic Initiatives & Impact Analysis by Key Market Participants
- 6.2. Company Categorization
- 6.3. Company Market Position Analysis
- 6.4. Strategy Mapping
- 6.5. Company Profiles
- 6.5.1. AbbVie Inc.
- 6.5.1.1. Participant's Overview
- 6.5.1.2. Financial Performance
- 6.5.1.3. Product Benchmarking
- 6.5.1.4. Recent Developments/ Strategic Initiatives
- 6.5.2. Afaxys, Inc.
- 6.5.2.1. Participant's Overview
- 6.5.2.2. Financial Performance
- 6.5.2.3. Product Benchmarking
- 6.5.2.4. Recent Developments/ Strategic Initiatives
- 6.5.3. Agile Therapeutics
- 6.5.3.1. Participant's Overview
- 6.5.3.2. Financial Performance
- 6.5.3.3. Product Benchmarking
- 6.5.3.4. Recent Developments/ Strategic Initiatives
- 6.5.4. Bayer AG
- 6.5.4.1. Participant's Overview
- 6.5.4.2. Financial Performance
- 6.5.4.3. Product Benchmarking
- 6.5.4.4. Recent Developments/ Strategic Initiatives
- 6.5.5. China Resources (Holdings) Co., Ltd.
- 6.5.5.1. Participant's Overview
- 6.5.5.2. Financial Performance
- 6.5.5.3. Product Benchmarking
- 6.5.5.4. Recent Developments/ Strategic Initiatives
- 6.5.6. Church & Dwight Co., Inc.
- 6.5.6.1. Participant's Overview
- 6.5.6.2. Financial Performance
- 6.5.6.3. Product Benchmarking
- 6.5.6.4. Recent Developments/ Strategic Initiatives
- 6.5.7. Cupid Limited
- 6.5.7.1. Participant's Overview
- 6.5.7.2. Financial Performance
- 6.5.7.3. Product Benchmarking
- 6.5.7.4. Recent Developments/ Strategic Initiatives
- 6.5.8. Helm AG
- 6.5.8.1. Participant's Overview
- 6.5.8.2. Financial Performance
- 6.5.8.3. Product Benchmarking
- 6.5.8.4. Recent Developments/ Strategic Initiatives
- 6.5.9. Johnson & Johnson Services, Inc.
- 6.5.9.1. Participant's Overview
- 6.5.9.2. Financial Performance
- 6.5.9.3. Product Benchmarking
- 6.5.9.4. Recent Developments/ Strategic Initiatives
- 6.5.10. Organon Group
- 6.5.10.1. Participant's Overview
- 6.5.10.2. Financial Performance
- 6.5.10.3. Product Benchmarking
- 6.5.10.4. Recent Developments/ Strategic Initiatives
- 6.5.11. Pfizer Inc.
- 6.5.11.1. Participant's Overview
- 6.5.11.2. Financial Performance
- 6.5.11.3. Product Benchmarking
- 6.5.11.4. Recent Developments/ Strategic Initiatives
- 6.5.12. Veru, Inc.
- 6.5.12.1. Participant's Overview
- 6.5.12.2. Financial Performance
- 6.5.12.3. Product Benchmarking
- 6.5.12.4. Recent Developments/ Strategic Initiatives
- 6.5.13. Viatris Inc.
- 6.5.13.1. Participant's Overview
- 6.5.13.2. Financial Performance
- 6.5.13.3. Product Benchmarking
- 6.5.13.4. Recent Developments/ Strategic Initiatives
- 6.5.1. AbbVie Inc.
Product Code: 978-1-68038-032-3
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 North America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 4 U.S. contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 5 Canada contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 6 Mexico contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 7 Europe contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 8 UK contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 9 Germany contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 10 France contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 11 Italy contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 12 Spain contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 13 Denmark contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 14 Sweden contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 15 Norway contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 16 Asia Pacific contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 17 Japan contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 18 China contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 19 India contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 20 Australia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 21 South Korea contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 22 Thailand contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 23 Latin America contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 24 Brazil contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 25 Argentina contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 26 MEA contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 27 South Africa contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 28 Saudi Arabia contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 29 UAE contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
- Table 30 Kuwait contraceptive drugs and devices market estimates and forecasts by product, 2018 - 2030 (USD Billion)
List of Figures
- Fig. 1 List of Figures
- Fig. 2 Contraceptive Drugs and Devices Market Segmentation
- Fig. 3 Information Procurement
- Fig. 4 Data Analysis Models
- Fig. 5 Market Formulation and Validation
- Fig. 6 Data Validating & Publishing
- Fig. 7 Market Snapshot
- Fig. 8 Segment Snapshot
- Fig. 9 Competitive Landscape Snapshot
- Fig. 10 Contraceptive Drugs and Devices- Market Size and Growth Prospects (USD Billion)
- Fig. 11 Contraceptive Drugs and Devices Market: Market Dynamics
- Fig. 12 Contraceptive Drugs and Devices Market: PORTER's Analysis
- Fig. 13 Contraceptive Drugs and Devices Market: PESTEL Analysis
- Fig. 14 Contraceptive Drugs and Devices Market Share by Product 2024 & 2030 (USD Billion)
- Fig. 15 Contraceptive Drugs and Devices Market, by Product: Key Takeaways
- Fig. 16 Contraceptive Drugs and Devices Market, by Product: Market Share, 2024 & 2030
- Fig. 17 Contraceptive Drugs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 18 Contraceptive Pills Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 19 Patch Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 20 Injectable Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 21 Contraceptive Devices Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 22 Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 23 Male Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 24 Female Condoms Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 25 Subdermal Implants Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 26 Intrauterine Devices (IUDs) Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 27 Copper IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 28 Hormonal IUDs Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 29 Vaginal Ring Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 30 Diaphragm Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
- Fig. 31 Contraceptive Drugs and Devices Market Revenue, by Region, 2024 & 2030 (USD Billion)
- Fig. 32 Regional Marketplace: Key Takeaways
- Fig. 33 Regional Marketplace: Key Takeaways
- Fig. 34 North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 35 U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 36 Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 37 Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 38 Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 39 UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030) (USD Billion)
- Fig. 40 Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 41 France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 42 Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 43 Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 44 Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 45 Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 46 Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 47 Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- Fig. 48 Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 49 China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 50 India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 51 Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 52 South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 53 Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 54 Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 55 Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 56 Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 57 MEA Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 58 Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 59 South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 60 UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 61 Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- Fig. 62 Key Company Categorization
- Fig. 63 Company Market Positioning
- Fig. 64 Key Company Market Share Analysis, 2024
- Fig. 65 Strategic Framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.